Key result
Endothelial mitochondrial dysregulation drives microvascular dysfunction in CAD, highlighting a novel therapeutic target.
Why the study?
The role of endothelial mitochondrial dynamics dysregulation in coronary artery disease-related microvascular dysfunction and its potential as a treatment target remained to be conceptualized.
Targeting mitochondrial dynamics may be a potential therapeutic strategy for treating endothelial microvascular dysfunction in patients with coronary artery disease.
May inform trials of mitochondrial modulators in CAD microvascular dysfunction; hypothesis-generating and should not yet change practice.
The endothelial microvasculature is essential for the regulation of vasodilation and vasoconstriction, and improved functioning of the endothelium is linked to improved outcomes for individuals with coronary artery disease (CAD). People with endothelial dysfunction exhibit a loss of nitric oxide (NO)-mediated vasodilation, achieving vasodilation instead through mitochondria-derived H 2 O 2 . Mitochondrial dynamics is an important autoregulatory mechanism that contributes to mitochondrial and endothelial homeostasis and plays a role in the formation of reactive oxygen species (ROS), including H 2 O 2 . Dysregulation of mitochondrial dynamics leads to increased ROS production, decreased ATP production, impaired metabolism, activation of pathological signal transduction, impaired calcium sensing, and inflammation. We hypothesize that dysregulation of endothelial mitochondrial dynamics plays a crucial role in the endothelial microvascular dysfunction seen in individuals with CAD. Therefore, proper regulation of endothelial mitochondrial dynamics may be a suitable treatment for individuals with endothelial microvascular dysfunction, and we furthermore postulate that improving this microvascular dysfunction will directly improve outcomes for those with CAD.
No takes yet. Share an insight, caveat, or question.
Gutierrez‐Huerta et al. (2024) conducted a review in Coronary artery disease and endothelial microvascular dysfunction. Regulation of mitochondrial dynamics was evaluated. Dysregulation of endothelial mitochondrial dynamics contributes to endothelial microvascular dysfunction in coronary artery disease, suggesting it as a potential therapeutic target.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: